1. Home
  2. ATAI vs CVLG Comparison

ATAI vs CVLG Comparison

Compare ATAI & CVLG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ATAI
  • CVLG
  • Stock Information
  • Founded
  • ATAI 2018
  • CVLG 1986
  • Country
  • ATAI Germany
  • CVLG United States
  • Employees
  • ATAI N/A
  • CVLG N/A
  • Industry
  • ATAI Biotechnology: Pharmaceutical Preparations
  • CVLG Trucking Freight/Courier Services
  • Sector
  • ATAI Health Care
  • CVLG Industrials
  • Exchange
  • ATAI Nasdaq
  • CVLG Nasdaq
  • Market Cap
  • ATAI 444.7M
  • CVLG 499.3M
  • IPO Year
  • ATAI 2021
  • CVLG 1994
  • Fundamental
  • Price
  • ATAI $2.66
  • CVLG $25.53
  • Analyst Decision
  • ATAI Strong Buy
  • CVLG Strong Buy
  • Analyst Count
  • ATAI 2
  • CVLG 2
  • Target Price
  • ATAI $11.00
  • CVLG $35.25
  • AVG Volume (30 Days)
  • ATAI 5.7M
  • CVLG 149.2K
  • Earning Date
  • ATAI 08-12-2025
  • CVLG 07-23-2025
  • Dividend Yield
  • ATAI N/A
  • CVLG 1.10%
  • EPS Growth
  • ATAI N/A
  • CVLG N/A
  • EPS
  • ATAI N/A
  • CVLG 1.39
  • Revenue
  • ATAI $1,863,000.00
  • CVLG $1,122,068,000.00
  • Revenue This Year
  • ATAI $554.22
  • CVLG $2.61
  • Revenue Next Year
  • ATAI N/A
  • CVLG $5.94
  • P/E Ratio
  • ATAI N/A
  • CVLG $18.49
  • Revenue Growth
  • ATAI 572.56
  • CVLG 0.59
  • 52 Week Low
  • ATAI $1.03
  • CVLG $17.46
  • 52 Week High
  • ATAI $2.99
  • CVLG $30.77
  • Technical
  • Relative Strength Index (RSI)
  • ATAI 62.17
  • CVLG 67.46
  • Support Level
  • ATAI $2.62
  • CVLG $24.82
  • Resistance Level
  • ATAI $2.99
  • CVLG $25.96
  • Average True Range (ATR)
  • ATAI 0.24
  • CVLG 0.64
  • MACD
  • ATAI 0.03
  • CVLG 0.14
  • Stochastic Oscillator
  • ATAI 67.01
  • CVLG 85.15

About ATAI ATAI Life Sciences N.V.

ATAI Life Sciences NV is a clinical-stage biopharmaceutical company on a mission to develop effective mental health treatments to transform patient outcomes. The company's pipeline of psychedelic-based therapies includes VLS-01 (buccal film DMT) for treatment-resistant depression (TRD) and EMP-01 (oral R-MDMA) for social anxiety disorder. It is also advancing a drug discovery program to identify novel, non-hallucinogenic 5-HT2AR agonists for TRD.

About CVLG Covenant Logistics Group Inc.

Covenant Logistics Group Inc together with its wholly-owned subsidiaries offers truckload transportation and freight brokerage services to customers throughout the continental United States. The company's reportable segments include Expedited, Dedicated Services, Managed Freight and Warehousing. Expedited segment provides truckload services to customers with high service freight and delivery standards. Dedicated segment provides customers with committed truckload capacity over contracted periods with the goal of three to five years in length. Managed Freight segment includes brokerage services and TMS. Warehousing segment provides day-to-day warehouse management services to customers who have chosen to outsource this function. Majority of revenue is generated from expedited segment.

Share on Social Networks: